factual

What is Learningrx's obligation regarding payment of reasonable costs associated with actions to protect its rights in Copyrighted Works, Confidential Information or Trade Secrets?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

You must notify us within three days after you learn about another's use of language, a visual image, or a recording of any kind, that you perceive to be identical or substantially similar to one of our Copyrighted Works or use of our Confidential Information or Trade Secrets or if someone challenges your use of our Copyrighted Works, Confidential Information or Trade Secrets. We will take whatever action we deem appropriate, in our sole and absolute discretion, to protect our rights in and to the Copyrighted Works, Confidential Information or Trade Secrets, which may include payment of reasonable costs associated with the action. However, the Franchise Agreement does not require us to take affirmative action in response to any apparent infringement of or challenge to your use of any Copyrighted Works, Confidential Information or Trade Secrets or claim by any person of any rights in any Copyrighted Works, Confidential Information or Trade Secrets. You must not directly or indirectly contest our rights to any of our Copyrighted Works, Confidential Information or Trade Secrets. You may not communicate with anyone except us and our counsel with respect to any infringement, challenge or claim. We will have discretion to take action as we deem appropriate regarding any infringement, challenge or claim, and the sole right to control exclusively any litigation or other proceeding arising out of any infringement, challenge or claim under any Copyrighted Works, Confidential Information or Trade Secrets. You must sign any and all instruments and documents, give the assistance, and do acts and things that may, in the opinion of our counsel, be necessary to protect and maintain our interests in any litigation or proceeding or to protect and maintain our interests in the Copyrighted Works, Confidential Information or Trade Secrets.

Source: Item 14 — PATENTS, COPYRIGHTS AND PROPRIETARY INFORMATION (FDD pages 37–40)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, Learningrx retains the sole and absolute discretion to take action to protect its Copyrighted Works, Confidential Information, and Trade Secrets. If a franchisee notifies Learningrx of potential infringement or challenges to these proprietary assets, Learningrx will decide what action, if any, to take.

Specifically, Learningrx may choose to cover reasonable costs associated with actions to protect its rights. However, the Franchise Agreement does not mandate that Learningrx take any affirmative action in response to apparent infringement or challenges. This means that while Learningrx has the option to act and potentially cover costs, it is not legally obligated to do so.

This discretion extends to controlling any litigation or proceedings arising from infringement, challenges, or claims related to Learningrx's Copyrighted Works, Confidential Information, or Trade Secrets. The franchisee is prohibited from contesting Learningrx's rights to these assets and must cooperate fully with Learningrx's legal efforts by signing documents and providing assistance as needed. Franchisees are also required to notify Learningrx within three days of learning about potential infringements.

In practical terms, a Learningrx franchisee needs to understand that while Learningrx may assist in protecting its intellectual property, it is not required to do so. The franchisee bears the risk that Learningrx may choose not to pursue legal action, even if there is a clear infringement. Therefore, franchisees should be prepared to potentially bear some costs or consequences if Learningrx decides not to act. This highlights the importance of carefully adhering to the confidentiality agreements and protecting Learningrx's proprietary information to minimize the risk of infringement or challenges.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.